This HTML5 document contains 155 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
n11http://dx.doi.org/10.18632/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q47110441
rdf:type
wikibase:Item
schema:description
vetenskaplig artikel bilimsel makale 2017年學術文章 artykuł naukowy artigo científico επιστημονικό άρθρο 2017年学术文章 научна статия artikel ilmiah articol științific 2017年學術文章 სამეცნიერო სტატია scientific article published on 15 November 2017 tieteellinen artikkeli 2017年學術文章 scientific article published on 15 November 2017 2017年学术文章 article científic article scientific 2017年学术文章 wetenschappelijk artikel bài báo khoa học 2017 nî lūn-bûn artigo científico tudományos cikk บทความทางวิทยาศาสตร์ wissenschaftlicher Artikel 2017年学术文章 naučni članak наукова стаття, опублікована в листопаді 2017 article scientifique teaduslik artikkel scientific article published on 15 November 2017 vedecký článok artikulong pang-agham 2017年學術文章 ১৫ নভেম্বর ২০১৭-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ мақолаи илмӣ 2017년 논문 artículu científicu מאמר מדעי vitenskapelig artikkel videnskabelig artikel artículo científico publicado en 2017 artigo científico научная статья 2017年学术文章 2017年學術文章 articolo scientifico научни чланак مقالة علمية نشرت في 15 نوفمبر 2017 vědecký článek artikull shkencor научни чланак vitskapeleg artikkel scienca artikolo 2017年学术文章 2017年の論文
p:P577
wds:Q47110441-91F7B894-9CAB-419B-B468-763D018E2CDB
wdt:P577
2017-11-15T00:00:00Z
p:P407
wds:Q47110441-1B6C3A45-6511-46B1-A87E-1DFBDB1B67E1
wdt:P407
wd:Q1860
p:P2860
wds:Q47110441-B0E5F24A-D6BD-4ED4-A3BE-B336E6ECB6FF wds:Q47110441-B297B668-9ACD-468B-8A1B-EBDDE8B30BE7 wds:Q47110441-A7D3A702-D34C-4AC0-B144-EF60EA8238AF wds:Q47110441-8104FE5D-F2E5-4207-9CDD-410583F56583 wds:Q47110441-71B0FF39-67BB-414B-AD0B-508831C6294F wds:Q47110441-4AD8869E-69A9-409D-AF0C-4CC525089066 wds:Q47110441-5B0268E3-6C15-4E57-BAE5-40FC6590C88B wds:Q47110441-5B7300A3-1EF3-4BA3-AC8D-58BDD84489B4 wds:Q47110441-65FE032A-CF19-4868-B468-79C22D5DB034 wds:Q47110441-1F3C7C12-6375-4DB0-B44B-F59680C7BDE2 wds:Q47110441-21123205-5205-42F6-B930-003740006859 wds:Q47110441-22AE1F3F-1B61-41B7-9D2D-E744F8FC8849 wds:Q47110441-0F6C477A-63E3-4048-9782-78D761695E17 wds:Q47110441-1EDAC470-E3F0-4822-9150-E9A84293D190 wds:Q47110441-02322D16-A867-4B85-B4C8-4359A7B4BFDC wds:Q47110441-0D24CE66-4169-484E-A8AB-0AAFCD5D46EC wds:Q47110441-FEB02E4A-F70B-4D2F-8F8A-2FCE4174CB4F wds:Q47110441-EB6E5D50-B7D1-4ACF-B395-D0DD6C54FCA8 wds:Q47110441-EB8F5126-3B23-4A3B-80CB-3472FB01DB91 wds:Q47110441-D93C4501-4037-45D5-B5DC-DB993DCDE603 wds:Q47110441-DE4BBAE3-9128-433E-8E20-65F490F596D9
wdt:P2860
wd:Q84001425 wd:Q56091932 wd:Q86067950 wd:Q73675166 wd:Q27860501 wd:Q45271357 wd:Q37199926 wd:Q77753426 wd:Q36772954 wd:Q42358557 wd:Q53402080 wd:Q33435442 wd:Q42591767 wd:Q38388028 wd:Q82326945 wd:Q37507375 wd:Q46666218 wd:Q46046507 wd:Q73668432 wd:Q42345754 wd:Q53557428
p:P2093
wds:Q47110441-6F927D06-DAC1-4E5B-8A7F-47F006D44B50 wds:Q47110441-F634055F-1CF9-438C-8381-79F7277430A1 wds:Q47110441-DE5C59A1-4652-49C6-B5F7-2F34FF59511E
wdt:P2093
Hiroshi Sasaki Shoji Kodama Harushige Yokota
rdfs:label
Effectiveness of adjuvant systemic chemotherapy for intermediate-risk stage IB cervical cancer. Effectiveness of adjuvant systemic chemotherapy for intermediate-risk stage IB cervical cancer.
skos:prefLabel
Effectiveness of adjuvant systemic chemotherapy for intermediate-risk stage IB cervical cancer. Effectiveness of adjuvant systemic chemotherapy for intermediate-risk stage IB cervical cancer.
schema:name
Effectiveness of adjuvant systemic chemotherapy for intermediate-risk stage IB cervical cancer. Effectiveness of adjuvant systemic chemotherapy for intermediate-risk stage IB cervical cancer.
p:P50
wds:Q47110441-133431AA-5A61-48CA-9F35-AABE13296C20 wds:Q47110441-463EB606-B9FE-4369-A20B-DFB978B43724 wds:Q47110441-6E5AE284-C758-48B0-B02B-5ACBB37AA18F wds:Q47110441-79DAF28B-0501-4019-B59E-7CA9C6A1BBF3 wds:Q47110441-92119043-14A6-4BCC-BF68-5D0A762D0E5A wds:Q47110441-94C92F7B-D050-4793-BE20-69804A53256B wds:Q47110441-D5C9A4F1-CB11-4299-BA3C-61DFC511BE7B
wdt:P50
wd:Q88144723 wd:Q42317571 wd:Q51754685 wd:Q89276961 wd:Q88144741 wd:Q61864013 wd:Q86480404
p:P1476
wds:Q47110441-D93C3A98-D896-4253-B8B3-574D38A7E20B
wdt:P1476
Effectiveness of adjuvant systemic chemotherapy for intermediate-risk stage IB cervical cancer
p:P304
wds:Q47110441-9ACA3CCA-1776-4543-B811-037D836427AE
wdt:P304
106866-106875
p:P31
wds:Q47110441-36DD3F38-E8FC-4F70-A78C-B664C0114B54
wdt:P31
wd:Q13442814
p:P921
wds:Q47110441-BCDAF7C9-F808-4453-9827-B5E5BCE572D9
wdt:P921
wd:Q160105
p:P698
wds:Q47110441-EE529739-668B-4129-B273-5D16B784D290
wdtn:P698
n9:29290995
wdt:P698
29290995
p:P1433
wds:Q47110441-80CA526C-41FA-4ACE-81D0-FF52AB60423B
wdt:P1433
wd:Q1573155
p:P433
wds:Q47110441-27832050-4319-4442-8141-0C436AD4E2D9
p:P478
wds:Q47110441-427EF36A-00B6-46B1-AB06-993AA50AE2D7
wdt:P433
63
wdt:P478
8
p:P356
wds:Q47110441-3C864DE3-C2A6-4F95-8E7A-7AF68C77B0EA
wdtn:P356
n11:ONCOTARGET.22437
wdt:P356
10.18632/ONCOTARGET.22437
p:P8608
wds:Q47110441-BCD64C4D-895F-4B13-96CC-06794E3FF612
wdt:P8608
release_ghbj6a75gva6va3xwy6ttaf7wy
p:P932
wds:Q47110441-94DE13C8-AB0F-4643-98ED-FF47DEEC7121
wdt:P932
5739780